Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 62, Number 5, March 09, 2004
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katsarava, Z.
Right arrow Articles by Limmroth, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katsarava, Z.
Right arrow Articles by Limmroth, V.
Related Collections
Right arrow All Headache
Right arrow Migraine
Right arrow All epidemiology
NEUROLOGY 2004;62:788-790
© 2004 American Academy of Neurology


Brief Communications

Incidence and predictors for chronicity of headache in patients with episodic migraine

Z. Katsarava, MD, S. Schneeweiss, MD, ScD, T. Kurth, MD, ScD, U. Kroener, BS, G. Fritsche, PhD, A. Eikermann, MD, H. -C. Diener, MD, PhD and V. Limmroth, MD

From the Department of Neurology (Drs. Katsarava, Fritsche, Eikermann, Diener, and Limmroth, U. Kroener), University Hospital Essen, Germany; and Divisions of Pharmacoepidemiology and Pharmacoeconomics (Dr. Schneeweiss) and Preventive Medicine and Aging (Dr. Kurth), Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA.

Address correspondence and reprint requests to Dr. V. Limmroth, Department of Neurology, University Hospital Essen, University of Essen, Hufelandstr. 55, 45122 Essen, Germany; e-mail: volker.limmroth{at}uni-essen.de

The authors followed 532 consecutive patients with episodic migraine (<15 days/month) for 1 year. Sixty-four patients (14%) developed chronic headache (>=15 days/month). The odds ratios for developing CH were 20.1 (95% CI 5.7 to 71.5) comparing patients with a "critical" (10 to 14 days/month) vs "low" (0 to 4 days/month) and 6.2 (95% CI 1.7 to 26.6) in patients with an "intermediate" (6 to 9 days/month) vs "low" headache frequency and 19.4 (95% CI 8.7 to 43.2) comparing patients with and without medication overuse.


Received July 15, 2003. Accepted in final form October 6, 2003.




This article has been cited by other articles:


Home page
NeurologyHome page
M. E. Bigal and R. B. Lipton
Excessive acute migraine medication use and migraine progression
Neurology, November 25, 2008; 71(22): 1821 - 1828.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
C W Duncan, D P B Watson, A Stein, and on behalf of the Guideline Development Group
Diagnosis and management of headache in adults: summary of SIGN guideline
BMJ, November 20, 2008; 337(nov20_1): a2329 - a2329.
[Full Text]


Home page
PNHome page
D W Dodick and S D Silberstein
Migraine prevention
Practical Neurology, November 1, 2007; 7(6): 383 - 393.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. B. Lipton, M. E. Bigal, M. Diamond, F. Freitag, M. L. Reed, W. F. Stewart, and on behalf of the AMPP Advisory Group
Migraine prevalence, disease burden, and the need for preventive therapy
Neurology, January 30, 2007; 68(5): 343 - 349.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. E. Bigal, J. N. Liberman, and R. B. Lipton
Age-dependent prevalence and clinical features of migraine.
Neurology, July 25, 2006; 67(2): 246 - 251.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. E. Bigal and R. B. Lipton
Obesity is a risk factor for transformed migraine but not chronic tension-type headache.
Neurology, July 25, 2006; 67(2): 252 - 257.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Paemeleire, A. Bahra, S. Evers, M. S. Matharu, and P. J. Goadsby
Medication-overuse headache in patients with cluster headache.
Neurology, July 11, 2006; 67(1): 109 - 113.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
V. K. Gupta
Orbitofrontal cortex hypometabolism, medication overuse headache, substance abuse and migraine: key pathophysiological issues.
Brain, July 1, 2006; 129(Pt 7): E52 - E52.
[Full Text] [PDF]


Home page
BrainHome page
A. Fumal, R. Kupers, and J. Schoenen
Reply: Orbitofrontal cortex hypometabolism, medication overuse headache, substance abuse and migraine: key pathophysiological issues
Brain, July 1, 2006; 129(7): E53 - E53.
[Full Text] [PDF]


Home page
BrainHome page
A. Fumal, S. Laureys, L. Di Clemente, M. Boly, V. Bohotin, M. Vandenheede, G. Coppola, E. Salmon, R. Kupers, and J. Schoenen
Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine
Brain, February 1, 2006; 129(2): 543 - 550.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. E. Bigal, A. M. Rapoport, F. D. Sheftell, S. J. Tepper, and R. B. Lipton
Chronic migraine is an earlier stage of transformed migraine in adults
Neurology, November 22, 2005; 65(10): 1556 - 1561.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. C. Lyngberg, B. K. Rasmussen, T. Jorgensen, and R. Jensen
Prognosis of migraine and tension-type headache: A population-based follow-up study
Neurology, August 23, 2005; 65(4): 580 - 585.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. I. Scher, W. F. Stewart, and R. B. Lipton
Caffeine as a risk factor for chronic daily headache: A population-based study
Neurology, December 14, 2004; 63(11): 2022 - 2027.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. B. Lipton and M. E. Bigal
Opioid therapy and headache: A cause and a cure
Neurology, May 25, 2004; 62(10): 1662 - 1663.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.